The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......
The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......
In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN......
India's drug regulator has granted restricted emergency use authorisation to Serum Institute's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions. IMAGE: A......
The Serum Institute of India on Friday sought permission from the Drugs Controller General of India (DCGI) to manufacture COVID-19 vaccine Covovax for restricted use in emergency situations at its......
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......
Amid concerns raised by domestic and international bodies that many medicines, especially antibiotics, are being misused in India, the drug regulator has ordered surprise inspections at chemists......
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices Even as the domestic pharmaceutical industry feels the heat of global scrutiny, the Drugs......
The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases. The delay by the health ministry in approving the sale of......
At a time India-made medicines appear to be losing sheen the world over, the country’s top regulator, the Drug Controller General of India (DCGI), is struggling to ensure quality of drugs in......